|
13 Feb 2007 |
QSV Biologics, Ltd., and Critical Biologics Corp., Sign Contract for cGMP Manufacture of Gelsolin for Critical Care Applications
|
|
09 Feb 2007 |
Zelos Therapeutics' Ostabolin-CTM Increases Bone Mineral Density in Phase 2 Osteoporosis Trial
|
|
09 Feb 2007 |
EU-Approval for Continuous Infusion of KOGENATE(R) Bayer
|
|
09 Feb 2007 |
LAB International Completes Patient Enrollment in Its Growth Hormone Releasing Hormone (GHRH) Product Phase IIA Trial
|
|
09 Feb 2007 |
Amarillo Biosciences Announces Open Enrollment in Its Phase 2 Study of Orally Administered Interferon Alpha in the Treatment of Oral Warts in HIV-Positive Patients
|
|
09 Feb 2007 |
Presentations at Stroke Conference Update Development of Viprinex(TM) (ancrod)
|
|
07 Feb 2007 |
Jerini expands collaboration with Baxter to develop non-intraveneous hemophilia therapy
|
|
07 Feb 2007 |
Gloucester Pharmaceuticals Announces Initiation of Phase I/II Clinical Trial in Patients with Multiple Myeloma
|
|
06 Feb 2007 |
Wyeth Pharmaceuticals and MediVas Announce Research Partnership to Develop Advanced Hemophilia Therapies
|
|
06 Feb 2007 |
Wyeth Pharmaceuticals and Nautilus Biotech Announce Collaboration to Develop Hemophilia Therapies
|
|
03 Feb 2007 |
Adnexus Therapeutics Announces Presentation Of Interim Phase I Results For CT-322, First Adnectin Therapeutic In Humans
|
|
02 Feb 2007 |
Overview On 2006 Sales Of TOP 20 Biologics To Be Released On February 26
|
|
02 Feb 2007 |
Pfizer to Acquire BioRexis to Access Novel Technology Platform and Early Stage Diabetes Pipeline
|
|
02 Feb 2007 |
Grifols announces FDA approval of Alphanate(R) to treat von Willebrand disease
|
|
02 Feb 2007 |
Successful Oral Insulin Toxicity Result - Oradel(TM), Loaded With Generic Insulin
|
|
31 Jan 2007 |
Gloucester Pharmaceuticals Receives Special Protocol Assessment for Pivotal Phase II Trial of Romidepsin in Patients with Peripheral T-Cell Lymphoma
|
|
31 Jan 2007 |
OctoPlus initiates Locteron Phase II clinical study in chronic hepatitis C
|
|
31 Jan 2007 |
ZymoGenetics Begins Clinical Trial for PEG-Interferon lambda as Potential Treatment for Viral Infection
|
|
31 Jan 2007 |
Alfacell Corporation Granted U.S. Orphan Drug Designation for ONCONASE(R) for Treatment of Malignant Mesothelioma
|
|
30 Jan 2007 |
ReceptoPharm Begins Phase IIb Human Clinical Trial for the Treatment of Adrenomyeloneuropathy
|
|
27 Jan 2007 |
Largest-ever stroke registry confirms safety of Actilyse(R) thrombolysis treatment for acute ischaemic stroke
|
|
26 Jan 2007 |
Bayer discontinues Trasylol(R) clinical trial program in non-CABG indications
|
|
26 Jan 2007 |
Spectrum Pharmaceuticals Initiates Phase 2b Trial for Ozarelix in Patients with Benign Prostate Hypertrophy
|
|
26 Jan 2007 |
Altea Therapeutics Announces Positive Clinical Results for its Basal Insulin Transdermal Patch
|
|
26 Jan 2007 |
BioMimetic Therapeutics Reports Positive Clinical Results Using GEM OS®1 to Treat Distal Radius Fractures
|
